This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the cancer treatment drug XOFIGO on a firm fixed price basis, with a potential value of $152,632.80. Cardinal Health 414 has provided a range of pharmaceutical products and services, including radiopharmaceuticals, to the VA, Department of Defense, and National Institutes of Health under various indefinite delivery contracts. This specific contract has no set-aside designation and was awarded on June 26, 2017, with a completion date of February 5, 2019. Cardinal Health 414 has delivered these products on a scheduled and emergency basis to support nuclear medicine, oncology, and other patient care programs at VA hospitals and clinics, military treatment facilities, and other federal health agencies.